ImExHS (IME) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
6 Jun, 2025Opening remarks and agenda
Meeting agenda included introductions, Chairman's and CEO's addresses, business of the meeting, and resolutions with proxy vote results.
Financial performance review
FY24 sales revenue increased 34% year-over-year and 27% on a constant currency basis.
Annual recurring revenue reached $26.5m, up 20% year-over-year.
Closing cash at $30.0m and debt at $25.8m as of 31 December 2024.
Underlying EBITDA improved to $2.1m from $0.2m in the prior year.
97% of total revenue is recurring.
Board and executive committee updates
Board comprises Doug Flynn (Chairman), Carlos Palacio, Dr Doug Lingard, Damian Banks, and CEO Dr German Arango.
Management team includes CFO Reena Minhas, COO Orlando Joven, and other key executives.
Partial view of Summaries dataset, powered by Quartr API
Latest events from ImExHS
- Revenue up 10%, EBITDA tripled to AUD 1.6m, ARR up 16%, and cash flow turned positive.IME
H2 20253 Mar 2026 - Revenue up 56.6% and ARR up 21%, but going concern risks remain due to cash outflows.IME
H1 202422 Jan 2026 - Revenue up 34% and ARR up 20%, driven by recurring income and margin improvements.IME
H2 202424 Dec 2025 - Q3 FY25 delivered 9% revenue and 24% ARR growth, margin gains, and reaffirmed FY25 guidance.IME
Q3 2025 TU13 Nov 2025 - ARR up 11% to $32.8m, revenue up 4%, with new product launches and FY25 growth guidance.IME
H1 202520 Oct 2025